The results showed that the model with low expression of KK-LC-1 on the surface of tumor cells was prone to relapse, and the model with high expression of KK-LC-1 could make the tumor regress after a single intravenous injection of KK-LC-1 TCR-Ts. Here, CT83 is linked to neoplasm.